Tag: Brussels Stock Exchange:BCART

New Study Led by Memorial

PRESS RELEASE: 4 May 2022, 07:00 CEST New Study Led by Memorial Sloan Kettering Cancer Center (NY, US) Shows Idylla™ GeneFusion Assay Enables More Rapid Screening of Targetable Fusions Compared to Routine ...

Press release Biocartis Group NV: Disclosure of a

PRESS RELEASE: REGULATED INFORMATION                                                                                4 February 2022, 07:00 CET Disclosure of a transparency notification Mechelen, Belgium, 4 February 2022 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics ...